© Copyright 2026, All Rights Reserved
Kynos Therapeutics is a biotechnology spinout from the University of Edinburgh that focuses on developing inflammation inhibitors for the treatment of conditions like acute pancreatitis. The company has progressed its lead molecule, KNS366, through clinical trials.